Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 5/20 | 0.36 |
| ▸ | CNR1 | P21554 | 2/20 | 0.36 |
| ▸ | SLC22A12 | Q96S37 | 4/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CTSL | P07711 | 1/20 | 0.30 |
| ▸ | CTSS | P25774 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CTSG | P08311 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8615237 | 0.91 | CNR2 (0.36) | CNR2CNR1ELANECTSG | |
| SCHEMBL216311 | 0.81 | NR1H2 (0.33) | — | |
| SCHEMBL30537733 | 0.76 | KDM4E (0.46) | CNR2CNR1SLC22A12KDM4EALDH1A1 | |
| SCHEMBL798769 | 0.76 | KDM4E (0.46) | CNR2CNR1SLC22A12KDM4EALDH1A1 | |
| SCHEMBL216178 | 0.76 | KDM4E (0.31) | KDM4EALDH1A1GAAHPGD | |
| SCHEMBL11057507 | 0.72 | ALDH1A1 (0.41) | CNR2CNR1SLC22A12KDM4EALDH1A1 | |
| SCHEMBL2966272 | 0.71 | — | — | |
| SCHEMBL11050977 | 0.70 | CNR2 (0.45) | CNR2CNR1SLC22A12KDM4EALDH1A1 | |
| SCHEMBL219317 | 0.70 | CYP2D6 (0.36) | KDM4EALDH1A1HPGD | |
| SCHEMBL2971433 | 0.70 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0837865-A1 | PROCESS FOR CONVERTING THE ACHIRAL MESO FORM OF AN ANSA-METALLOCENE COMPLEX INTO THE CHIRAL RACEMIC FORM | BASF AKTIENGESELLSCHAFT (DE) | 1998-04-29 | — | — | EP | disclosed |
| WO-1997003080-A1 | PROCESS FOR CONVERTING THE ACHIRAL MESO FORM OF AN ANSA-METALLOCENE COMPLEX INTO THE CHIRAL RACEMIC FORM | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-30 | — | — | WO | disclosed |